Healthcare
The healthcare industries are diverse and ever-expanding. Stringently regulated, globally competitive and often brand dependent, the medical device, pharmaceutical and consumer healthcare industries rely on stringent testing, problem-solving analysis and development consultancy.
Latest news - we will be talking about our inorganic Controlled Release Technologies at the Controlled Release Conference in London, 28-29 March.
At Ceram, thanks to our materials expertise, state-of-the-art facilities and industry-savvy technical consultants, we can help manufacturers and suppliers to comply with regulations, stay ahead of the competition and increase profitability.
Medical Devices
As a leading independent materials testing, analysis and consultancy organisation to the medical device industry, Ceram's knowledge of products, packaging, materials and chemistry is both extensive and diverse in the medical devices sector.
Consumer Healthcare
From shampoo, toothpaste and deodorant to soap and skincare products, we offer materials formulation, compositional analysis, identification and quantification analysis, performance and product marketing support testing, competitor product analysis and packaging failure analysis across a wide range of consumer healthcare products.
Pharmaceutical
Thanks to our materials expertise, analytical capabilities and consultancy services, we are able to work with pharmaceutical manufacturers and those along the supply chain to add value to products, optimise manufacturing routes and solve problems.
Innovation for Healthcare
Ceram is leading the way in materials innovation by developing a portfolio of new materials and technologies for its clients - particularly in the healthcare industries - medical devices, personal care and pharmaceuticals.
Case Studies:
Cleanliness Validation of Orthopaedic Implants for Joint Replacement Instrumentation Ltd
Surface contamination investigation
Plasma Treatment of Inhaler Cans for Bespak
Investigation of plasma deposition of a surface modifier in inhaler cans
Ceram Helps GlaxoSmithKline to Compare Fluoride Penetration of Sensodyne with Competitive Products
Analysis by dynamic secondary ion mass spectrometry
